Atul Pande Immunovant, Inc. (IMVT) insider trading activity

IMVT Quotes by TradingView

Atul Pande is Director of Immunovant, Inc.. Currently has a direct ownership of 94,413 shares of IMVT, which is worth approximately $2.6 Million. The most recent transaction as insider was on Apr 02, 2024, when has been sold 11,255 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 94.4K
0% 3M change
1.15% 12M change
Total Value Held $2.6 Million

Atul Pande Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 02 2024
BUY
Grant, award, or other acquisition
-
11,255 Added 10.65%
94,413 Common Stock
Dec 01 2023
SELL
Open market or private sale
$490,171 $39.69 p/Share
12,350 Reduced 12.93%
83,158 Common Stock
Apr 12 2023
BUY
Grant, award, or other acquisition
-
12,523 Added 11.59%
95,508 Common Stock
Aug 17 2022
BUY
Grant, award, or other acquisition
-
21,059 Added 20.24%
82,985 Common Stock
Jan 10 2022
BUY
Grant, award, or other acquisition
-
21,726 Added 25.97%
61,926 Common Stock
Mar 19 2021
BUY
Grant, award, or other acquisition
-
15,500 Added 27.83%
40,200 Common Stock

Also insider at

KRTX
Karuna Therapeutics, Inc. Healthcare
SIOX
Sio Gene Therapies Inc. Healthcare
Director
AP

Atul Pande

Director
New York, NY

Track Institutional and Insider Activities on IMVT

Follow Immunovant, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMVT shares.

Notify only if

Insider Trading

Get notified when an Immunovant, Inc. insider buys or sells IMVT shares.

Notify only if

News

Receive news related to Immunovant, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IMVT